Delta-Fly Pharma (4598) · InitiativeRestatedLatest Share Issuance and Disposal (2026-10-01): "Advanced"
Issuance and redemption of bonds
First written in FY2026-H1. 11 of 17 entries say "Advanced", first in 2026-05-15. Latest entry: 2026-10-01.
17entries
2years
15from disclosures
How it moved
Same theme, other companies
Financing Through Long-Term Borrowings and Bonds and the Shift in Debt StructureA theme 88 companies write about · 12 as a headwind · 37 as a tailwind
15 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 88 companies compared. The sentences above are computed from all 88.Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「Proceeds from the issuance of bonds: ¥250 million; payments for the redemption of bonds: ¥250 million」
当事業年度のキャッシュ・フロー計算書でも、社債の発行と同額の償還が記載され、社債取引を実施した事実を再確認している。 - FY2026-H1First statedAnnual report
「Proceeds from the issuance of bonds: ¥250 million; payments for the redemption of bonds: ¥250 million」
当中間会計期間に社債を250百万円発行するとともに、250百万円を償還した。発行と償還が同額であり、財務活動における社債取引の実施が初めて記載された。